Tony Pawson Tony Pawson was an undergraduate at the University of Cambridge, England (1970-1973), and obtained his Ph.D. at the Imperial Cancer Research Fund in London with Dr. Alan Smith, working on retroviral gene expression. He undertook postdoctoral work at the University of California at Berkeley with G. Steven Martin (1976-1980), where he identified a variety of retroviral oncogene products, and provided early evidence for the role of tyrosine phosphorylation in malignant transformation. He moved to the University of British Columbia, Vancouver as an Assistant Professor in 1981, and then to the Samuel Lunenfeld Research Institute of Mt. Sinai Hospital, University of Toronto, in 1985. Over the last 25 years has explored the mechanisms through which cell surface receptors control intracellular signaling pathways, and the organization of cell regulatory systems, building on his identification of the SH2 domain as the prototypic interaction module. Tony Pawson is a University Professor of the University of Toronto, Director of Research at the Samuel Lunenfeld Research Institute of Mt. Sinai Hospital, and a Distinguished Scientist of the Canadian Institutes for Health Research. He has received a number of awards, including the Gairdner Foundation International Award, the AACR/Pezcoller International Award for Cancer Research, the Heineken Prize for Biochemistry and Biophysics ( Royal Netherlands Academy of Arts and Scences) , the Killam Prize for Health Sciences, the Louisa Gross Horwitz Prize, the Wolf Prize in Medicine, and the Royal Medal from the Royal Society. He is a Fellow of the Royal Societies of London and Canada, a Foreign Associate of the National Academy of Sciences (US), an Associate Member of EMBO, and a recipient of the Order of Canada.